India’s injectable segment is no longer a small corner of pharma. It’s one of the fastest-growing parts of the whole industry. That’s why more distributors now look at the injectable PCD pharma franchise company model each year.
There are fewer players. Margins are better. And it’s a segment that hospitals simply can’t do without. A good injectable PCD pharma franchise company in India can turn that gap into a real business.
Why the Injectable PCD Pharma Franchise Company Model is Growing
Here’s the plain truth.
India’s generic injectables market was worth ₹25,050 Crore in 2024. IMARC Group says it will reach ₹63,460 Crore by 2033. That’s a CAGR of around 10.28%. This is not slow growth. The market could nearly triple within a decade.
Mordor Intelligence backs this up too. Their data shows injectables growing at almost 7% a year through 2031. Sterile plant capacity and biologics are driving much of this. Anti-infectives still lead the pack. They hold over a third of the market. But oncology injections are catching up fast.
The third-party injection manufacturing market is projected to become a ₹ 41,714 crore industry by 2033. In fact, India makes up 6.9% of the global sterile injectable contract manufacturing market.
What does this mean for you? Demand for an injection PCD franchise in India isn’t slowing down. Hospitals need a steady stock of antibiotics, heart drugs, and pain-relief shots. Small-town clinics are still underserved. Someone has to fill that gap. Franchise partners are doing much of that work right now.
Flanca Lifesciences: A Name Worth Knowing in This Space
If you are looking for an injectable PCD pharma franchise, Flanca Lifesciences has got you covered. The company runs WHO-GMP-compliant units.
It focuses on the injectable range franchise: vials, ampoules, dry powder shots, and prefilled formats. Its range spans anti-infectives, pain relief, and cardiac care. This focus matters a lot.
Flanca Lifesciences has built its name on quality products and timely delivery. That’s why so many partners come back for new territories. A PCD pharma franchise for an injectable range you can count on!
Why Distributors Are Choosing Injectables over Tablets
Tablets and capsules sit in a crowded market, which can impact your margins. There are too many companies convincing the same doctor with near-identical products.
Injectables work differently.
Higher Entry Barrier
The entry barrier is higher here. CDSCO’s strict rules for sterile plants mean not every firm can make injectables well. This keeps the field smaller.
Low Competition
Fewer rivals in your area mean less price-cutting. It also means stronger monopoly rights for you. Hospital orders tend to be bigger too. They’re steadier than retail chemist sales, since hospitals buy in bulk on a fixed schedule.
Strong Demand
Doctor demand is strong as well. Doctors treating cancer, heart disease, and critical illness lean on injections more than ever. An injectable PCD pharma franchise company that keeps its cold chain tight and its paperwork clean becomes a preferred partners for hospitals.
How to Pick the Right Injectable Range Franchise Partner
While opting for an injectable PCD pharma option is a lucrative venture, you need to choose the right partner. After all, you will be sourcing all products from them. These products will be as efficient as their manufacturing practices.
Therefore, check these factors while choosing the right injectable range franchise partner.
Manufacturing credentials: First of all, make sure they have WHO-GMP and ISO certifications in place. These certifications show that the company follows international standards of manufacturing. Also, check if these certifications are about to expire or are renewed.
Product range: A narrow list limits what you can offer doctors. Look for coverage across anti-infectives, pain relief, cardiac, and gastro shots at the least. This is what we offer at Flanca Lifesciences with our wide range. This way, pharma businesses get all products under one roof, meaning that they don’t need to work with 3-4 partners for different items.
Territory protection: One of the key benefits of a PCD pharma franchise is that it lets you be the sole vendor of the company in your area. This is called monopoly rights. With these rights, no other vendor of your chosen pharma company will be operating in your assigned region. However, make sure to get it in writing.
Supply reliability: Ask about average dispatch time. A firm that promises 500 products but ships in six weeks is not a partner. It’s a problem waiting to happen.
Marketing support: Visual aids, free samples, and product literature help a lot. They matter most when you’re building doctor ties from scratch.
Flanca Lifesciences ticks each box here. That’s worth weighing if you’re comparing a PCD pharma franchise for injectable range, rather than settling for the first firm that replies to your enquiry.
Getting Started as an Injectable Franchise Partner
The process itself is simple once you’ve picked the right injectable PCD pharma franchise company to work with.
- You’ll need a valid drug licence, GST registration, and cash for your first stock order. The exact figure depends on your product range and territory size. Most firms, Flanca Lifesciences included, walk new partners through the paperwork.
- Once you’re on board, you get monopoly rights over your area.
- You also get a fixed product list and marketing material to start doctor visits.
- Revenue usually builds over the first six to twelve months, as you build ties with prescribers. Unlike seasonal products, injectables tend to see steady demand all year.
The Road Ahead
India’s injectable manufacturing base keeps growing. Government PLI schemes are funding new sterile plants. Hospital infrastructure is spreading into smaller cities under schemes like Ayushman Bharat. All of this points to strong, lasting demand for injectable therapy over the next decade.
If you’re serious about a pharma distribution business with real staying power, injectables deserve a proper look. Flanca Lifesciences is worth a spot on your shortlist when you start comparing partners.
Frequently Asked Questions
Q. What is an injectable PCD pharma franchise company?
Ans. It’s a pharma company that produces injectable drugs. It grants exclusive rights to market and sell in a specific territory to distributors under a franchise model.
Q. How much does it cost to open an injection PCD franchise in India?
Ans. The initial investment usually varies from ₹2 Lakh to ₹10 Lakh. This includes stock, registration and basic marketing material, but the cost varies from company to company.
Q. Do I need a drug licence to start an injectable range franchise?
Yes. To join any franchise firm, you need to have a valid wholesale or retail drug licence along with GST registration.
Q. What documents does Flanca Lifesciences require from new partners?
Normally, a copy of the drug licence, GST certificate, PAN card and signed franchise agreement defining territory and product terms.
Q. Why choose a PCD pharma franchise for an injectable range rather than tablets?
Injectables have higher manufacturing barriers. This leads to lesser competition, stronger monopoly rights and steady orders from hospitals and clinics.
Q. Does Flanca Lifesciences provide monopoly rights?
Yes. Flanca Lifesciences gives territory-based monopoly rights to its partners, under its standard franchise terms.
Q. What products sit in Flanca Lifesciences’ injectable range?
The range covers anti-infectives, pain relief, cardiac care, and general injections, in vials, ampoules, and dry powder formats.
Q. How soon will a new franchise partner see returns?
Most partners see steady orders within six to twelve months, as doctor ties and repeat hospital orders build up.
Q. Is WHO-GMP status important when choosing a franchise firm?
Yes, it is. It’s what qualifies your products for hospital tenders and government orders, which make up a large share of injectable sales.
Q. How do I get in touch with Flanca Lifesciences to start a franchise?
Contact us at +91 9888712784. The team there can guide you through open territories, product lists and the onboarding steps.